Pharmaceuticals, Biotechnology and Life Sciences
HONG KONG–(BUSINESS WIRE)–TAKE2 HEALTH LTD. (“TAKE2”), a healthcare technology company based in Hong Kong, China, today announced that it has…
ROSEMONT, Ill.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CSO?src=hash" target="_blank"gt;#CSOlt;/agt;–Proteintech, the benchmark in antibodies and proteins, welcomes Deepa Shankar, PhD, as the head of global…
– Presentations at AUA2019 explore Axumin detection rate and relationship to PSA levels, based on extent of recurrence and prior…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/INDstatus?src=hash" target="_blank"gt;#INDstatuslt;/agt;–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/INDstatus?src=hash" target="_blank"gt;#INDstatuslt;/agt;–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for…
SEATTLE–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CAS?src=hash" target="_blank"gt;#CASlt;/agt;–According to Coherent Market Insights, the global CRISPR and CAS gene Market was valued at US$ 1,388.1…
ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that patient enrollment has been completed in the Phase 3 RESET (Rivipansel:…
Phase 3 drug candidate targeting molluscum SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the acquisition of economic rights to…
SL-279252 is the first Agonist Redirected Checkpoint molecule to enter clinical development from the Shattuck pipeline. AUSTIN, Texas–(BUSINESS WIRE)–Shattuck Labs,…
Dr. Brandt to Provide Translational Research Expertise and Clinical Support Advisory Services MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc”),…